By Topic

In vivo evaluation of a new ultrasound contrast agent

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

5 Author(s)

An ultrasound contrast agent (EchoGen; Sonus Pharmaceuticals, Bothell, WA) was evaluated in vivo. The agent changes at body temperature from non-echogenic submicron liquid droplets to echogenic gas microbubbles (1-2 μm*) capable of traversing the pulmonary and capillary circulations. IV injections were given to 5 woodchucks, 4 dogs and 12 rabbits (dose: 0.05-0.8 ml/kg). Color Doppler, color amplitude and B-mode images were acquired from kidneys and vessels. A segmental branch of the renal artery was ligated providing a model of ischemia. Increased flow signal intensities were observed for 2-3 minutes. Normal vessels and the area of ischemia were visualized using both color modes. An in vivo dose response curve was calculated. The curve was nonlinear with 18.7 dB maximum enhancement. Parenchymal enhancement was observed, and uptake and washout curves generated. Enhancement lasted 20 minutes. Ischemia was also seen using B-mode. In conclusion, EchoGen produces vascular and parenchymal enhancement. Ischemia was seen with all imaging modes

Published in:

Ultrasonics Symposium, 1994. Proceedings., 1994 IEEE  (Volume:3 )

Date of Conference:

Oct. 31 1994-Nov. 3 1994